iBio, Inc. (IBIO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Aug 24, 16:00
1.41
-0.01
(-0.70%)
After-Hours: 07:43
iBio Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -189.0% |
| June 30, 2025 | -42.50% |
| March 31, 2025 | |
| December 31, 2024 | -40.50% |
| September 30, 2024 | |
| June 30, 2024 | -60.57% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -400.0% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 44.72% |
| December 31, 2021 | |
| September 30, 2021 | -864.3% |
| June 30, 2021 | -66.40% |
| March 31, 2021 | -42.61% |
| December 31, 2020 | -15.32% |
| September 30, 2020 | -68.54% |
| June 30, 2020 | 23.04% |
| March 31, 2020 | -570.8% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -- |
| Ocugen, Inc. | 60.62% |
| CytomX Therapeutics, Inc. | 96.69% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.79% |
| Return on Assets | -53.78% |
| Return on Invested Capital | -59.54% |
| Return on Net Operating Assets | -262.6% |